Global and Region Cancer Testing/Screening Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The report details the trend, potential and market size of Cancer Testing/Screening market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Cancer Testing/Screeningmarket, defines the market attractiveness level of Cancer Testing/Screening market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Cancer Testing/Screening industry, describes the types of Cancer Testing/Screening market, the applications of major players and the market size, and deeply analyzes the current situation of the global Cancer Testing/Screening market and the development prospects and opportunities of Cancer Testing/Screening industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Cancer Testing/Screening market in Chapter 13.

    By Player:

    • Genextropy

    • Epigenetics

    • Techlab

    • 20/20 GeneSystems

    • M Genomics

    • Dias Orin

    • Abbott Laboratories

    • Positive Bioscience

    • AB SCIEX

    By Type:

    • Lung Cancer

    • Blood Cancer

    • Bone Cancer

    • Gall Bladder Cancer

    • Others

    By End-User:

    • Hospitals and Clinics

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Cancer Testing/Screening Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Cancer Testing/Screening Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Cancer Testing/Screening Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Cancer Testing/Screening Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Cancer Testing/Screening Market Analysis and Outlook to 2022

    • 7.1 Global Cancer Testing/Screening Consumption (2017-2022)

    • 7.2 United States Cancer Testing/Screening Consumption (2017-2022)

    • 7.3 Europe Cancer Testing/Screening Consumption (2017-2022)

    • 7.4 China Cancer Testing/Screening Consumption (2017-2022)

    • 7.5 Japan Cancer Testing/Screening Consumption (2017-2022)

    • 7.6 India Cancer Testing/Screening Consumption (2017-2022)

    • 7.7 South Korea Cancer Testing/Screening Consumption (2017-2022)

    8 Region and Country-wise Cancer Testing/Screening Market Analysis and Outlook to 2028

    • 8.1 Global Cancer Testing/Screening Consumption Forecast (2022-2028)

    • 8.2 United States Cancer Testing/Screening Consumption Forecast (2022-2028)

    • 8.3 Europe Cancer Testing/Screening Consumption Forecast (2022-2028)

    • 8.4 China Cancer Testing/Screening Consumption Forecast (2022-2028)

    • 8.5 Japan Cancer Testing/Screening Consumption Forecast (2022-2028)

    • 8.6 India Cancer Testing/Screening Consumption Forecast (2022-2028)

    • 8.7 South Korea Cancer Testing/Screening Consumption Forecast (2022-2028)

    9 Global Cancer Testing/Screening Market Outlook by Types and Applications to 2022

    • 9.1 Global Cancer Testing/Screening Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Lung Cancer Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Blood Cancer Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Bone Cancer Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Gall Bladder Cancer Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Cancer Testing/Screening Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals and Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Cancer Testing/Screening Market Outlook by Types and Applications to 2028

    • 10.1 Global Cancer Testing/Screening Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Blood Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Bone Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Gall Bladder Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Cancer Testing/Screening Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals and Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Cancer Testing/Screening Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Cancer Testing/Screening Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Cancer Testing/Screening Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Cancer Testing/Screening Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Cancer Testing/Screening Market Competitive Analysis

    • 14.1 Genextropy

      • 14.1.1 Genextropy Company Details

      • 14.1.2 Genextropy Cancer Testing/Screening Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Genextropy Cancer Testing/Screening Product and Service

    • 14.2 Epigenetics

      • 14.2.1 Epigenetics Company Details

      • 14.2.2 Epigenetics Cancer Testing/Screening Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Epigenetics Cancer Testing/Screening Product and Service

    • 14.3 Techlab

      • 14.3.1 Techlab Company Details

      • 14.3.2 Techlab Cancer Testing/Screening Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Techlab Cancer Testing/Screening Product and Service

    • 14.4 20/20 GeneSystems

      • 14.4.1 20/20 GeneSystems Company Details

      • 14.4.2 20/20 GeneSystems Cancer Testing/Screening Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 20/20 GeneSystems Cancer Testing/Screening Product and Service

    • 14.5 M Genomics

      • 14.5.1 M Genomics Company Details

      • 14.5.2 M Genomics Cancer Testing/Screening Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 M Genomics Cancer Testing/Screening Product and Service

    • 14.6 Dias Orin

      • 14.6.1 Dias Orin Company Details

      • 14.6.2 Dias Orin Cancer Testing/Screening Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Dias Orin Cancer Testing/Screening Product and Service

    • 14.7 Abbott Laboratories

      • 14.7.1 Abbott Laboratories Company Details

      • 14.7.2 Abbott Laboratories Cancer Testing/Screening Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Abbott Laboratories Cancer Testing/Screening Product and Service

    • 14.8 Positive Bioscience

      • 14.8.1 Positive Bioscience Company Details

      • 14.8.2 Positive Bioscience Cancer Testing/Screening Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Positive Bioscience Cancer Testing/Screening Product and Service

    • 14.9 AB SCIEX

      • 14.9.1 AB SCIEX Company Details

      • 14.9.2 AB SCIEX Cancer Testing/Screening Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 AB SCIEX Cancer Testing/Screening Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Cancer Testing/Screening

    • Figure Cancer Testing/Screening Picture

    • Table Global Cancer Testing/Screening Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Cancer Testing/Screening Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Cancer Testing/Screening Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Cancer Testing/Screening Consumption by Country (2017-2022)

    • Figure United States Cancer Testing/Screening Consumption and Growth Rate (2017-2022)

    • Table Europe Cancer Testing/Screening Consumption and Growth Rate (2017-2022)

    • Figure China Cancer Testing/Screening Consumption and Growth Rate (2017-2022)

    • Figure Japan Cancer Testing/Screening Consumption and Growth Rate (2017-2022)

    • Figure India Cancer Testing/Screening Consumption and Growth Rate (2017-2022)

    • Figure South Korea Cancer Testing/Screening Consumption and Growth Rate (2017-2022)

    • Figure Global Cancer Testing/Screening Consumption Forecast by Country (2022-2028)

    • Figure United States Cancer Testing/Screening Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Cancer Testing/Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Cancer Testing/Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Cancer Testing/Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Cancer Testing/Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Cancer Testing/Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lung Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Blood Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Bone Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Gall Bladder Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals and Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Blood Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Bone Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Gall Bladder Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals and Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Cancer Testing/Screening Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Cancer Testing/Screening Export by Region (Top 5 Countries) (2017-2028)

    • Table Genextropy (Foundation Year, Company Profile and etc.)

    • Table Genextropy Cancer Testing/Screening Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genextropy Cancer Testing/Screening Product and Service

    • Table Epigenetics (Foundation Year, Company Profile and etc.)

    • Table Epigenetics Cancer Testing/Screening Sales, Price, Value and Gross Profit (2017-2022)

    • Table Epigenetics Cancer Testing/Screening Product and Service

    • Table Techlab (Foundation Year, Company Profile and etc.)

    • Table Techlab Cancer Testing/Screening Sales, Price, Value and Gross Profit (2017-2022)

    • Table Techlab Cancer Testing/Screening Product and Service

    • Table 20/20 GeneSystems (Foundation Year, Company Profile and etc.)

    • Table 20/20 GeneSystems Cancer Testing/Screening Sales, Price, Value and Gross Profit (2017-2022)

    • Table 20/20 GeneSystems Cancer Testing/Screening Product and Service

    • Table M Genomics (Foundation Year, Company Profile and etc.)

    • Table M Genomics Cancer Testing/Screening Sales, Price, Value and Gross Profit (2017-2022)

    • Table M Genomics Cancer Testing/Screening Product and Service

    • Table Dias Orin (Foundation Year, Company Profile and etc.)

    • Table Dias Orin Cancer Testing/Screening Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dias Orin Cancer Testing/Screening Product and Service

    • Table Abbott Laboratories (Foundation Year, Company Profile and etc.)

    • Table Abbott Laboratories Cancer Testing/Screening Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Laboratories Cancer Testing/Screening Product and Service

    • Table Positive Bioscience (Foundation Year, Company Profile and etc.)

    • Table Positive Bioscience Cancer Testing/Screening Sales, Price, Value and Gross Profit (2017-2022)

    • Table Positive Bioscience Cancer Testing/Screening Product and Service

    • Table AB SCIEX (Foundation Year, Company Profile and etc.)

    • Table AB SCIEX Cancer Testing/Screening Sales, Price, Value and Gross Profit (2017-2022)

    • Table AB SCIEX Cancer Testing/Screening Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.